Scynexis (SCYX) Capital Expenditures (QoQ) (2013 - 2021)
Powered by 
Analysis
Scynexis (SCYX) Capital Expenditures (QoQ) (2013 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -303.40% |
| Sep 30, 2021 | 64.34% |
| Jun 30, 2021 | -19.66% |
| Dec 31, 2018 | 31.34% |
| Sep 30, 2018 | -83.25% |
| Jun 30, 2018 | 3,900.00% |
| Mar 31, 2017 | -33.33% |
| Dec 31, 2016 | -70.00% |
| Mar 31, 2016 | -66.67% |
| Dec 31, 2015 | 110.00% |
| Sep 30, 2015 | -94.38% |
| Jun 30, 2015 | 108.19% |
| Mar 31, 2015 | 137.50% |
| Dec 31, 2014 | -76.70% |
| Sep 30, 2014 | 24.10% |
| Jun 30, 2014 | 236.49% |
| Mar 31, 2014 | 21.31% |
| Dec 31, 2013 | 7.02% |
| Sep 30, 2013 | 21.28% |
| Jun 30, 2013 | -82.33% |